Skip to main content

Boston Scientific Value Stock - Dividend - Research Selection

Boston Scientific

ISIN: US1011371077, WKN: 884113

Market price date: 06.07.2022
Market price: 37,66 USD


Boston Scientific Fundamental data and company key figures of the share

Annual reports in USD
Key figures 04-03-2022
Cash flow
Net operating cash flow 1.870.000.000
Capital Expenditures -554.000.000
Free cash flow 1.316.000.000
Balance sheet
Total Equity 16.622.000.000
Liabilities & Shareholders equity 32.229.000.000
Income statement
Net income 1.041.000.000
Eps (diluted) 0,690
Diluted shares outstanding 1.416.000.000
Net sales/revenue 11.888.000.000

Fundamental ratios calculated on: 06-07-2022

Ratios
Key figures 06-07-2022
Cash flow
P/C 28,52
   
P/FC 40,52
Balance sheet
ROI3,23
ROE51,58
Income statement
P/E54,58
Div. Yield0,00%
P/B3,21
P/S4,49


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolBSX
Market Capitalization53.326.561.280,00 USD
CountryUnited States
IndicesMSCI World Index,S&P 500
SectorsHealth Care Equipment
Raw Data SourceUS GAAP in Millionen USD
Stock Split2003-11-06,2.0000/1.0000; 1998-12-01,2.0000/1.0000
Internetwww.bostonscientific.com


Description of the company

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women's Health, Neuromodulation, and Electrophysiology. In January 2011, it completed the acquisition of Intelect Medical, Inc. In June 2012, the Company acquired Cameron Health, Inc. of San Clemente, California and, as a result, added to its product portfolio subcutaneous implantable cardioverter defibrillator, called the S-ICD System. In November 2013, the Company announced that it has acquired Bard EP, the electrophysiology (EP) business of C.R. Bard, Inc.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.bostonscientific.com


NEWS


Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

2022-07-06
Rocket Companies upgrade, Coinbase downgrade and Abbott initiation among today's top calls on Wall Street RKT, SABR, ENTA, DNB, MERC, COIN, MCK, UHS, HCA, RNG, MSFT, KRNT, ABT, MDT, BSX, TFX, HWM, AVID, MTRN

These Mass. companies have lost at least $10B each in market cap this year

2022-07-06
The plunging stock market has wiped out billions of dollars in market capitalization for major public companies across Massachusetts.

Wolfe Research starts 'Goldilocks stock' Boston Scientific at Outperform

2022-07-06
Wolfe Research analyst Mi... BSX, ABT, MDT

'Minions' vs. 'Lightyear:' Here's why the silly yellow blobs beat Buzz at the box office

2022-07-05
'Minions' and 'Toy Story' are among the most popular and profitable franchises for their respective studios — so why did "Minions" soar and "Lightyear" flop?

Bottom in med tech shares is 'getting close,' says Piper Sandler

2022-07-05
Piper Sandler analysts be... BSX, HSIC, ATRC, AXNX, LIVN, PDCO, TNDM

Boston Scientific initiated with an Outperform at Wolfe Research

2022-07-05
Wolfe Research analyst Mi... BSX

'Minions: The Rise of Gru' tops $108 million as parents flock back to cinemas, kids in tow

2022-07-03
"Minions: The Rise of Gru" generated more than $108 million in ticket sales during its domestic opening weekend.

Trading The Top 10 Stocks From 40 Large Hedge Funds: Trading Update 7/2/2022

2022-07-03
We report the most recent holdings and the trading signals for 7/5/2022. Click here to know more.

Belo Sun Announces 2022 AGM Voting Results

2022-06-30
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

As a Triple Minority, Shae Finally Feels Seen at Boston Scientific

2022-06-30
Shae Wilson grew up in a military family, bouncing around from California to Japan, and then to North Carolina where her family finally settled and put down roots.